Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study
Ian Kracalik(Centers for Disease Control and Prevention), Jacek M. Mazurek, Chandra Barnes, Stephanie L Boles, John R. Su, Kimberly Badger, Jyothi Gunta, Paige Marquez(Centers for Disease Control and Prevention), Sridhar V. Basavaraju(Centers for Disease Control and Prevention), Agape Assefa(Centers for Disease Control and Prevention), E.D. Collins, Jeffrey M. Dendy(Vanderbilt University Medical Center), Maleeka Glover(Centers for Disease Control and Prevention), Tom T. Shimabukuro(Centers for Disease Control and Prevention), Jennifer Lehman, Jared Woo(Centers for Disease Control and Prevention), Susan Karol, Jonathan H. Soslow(Vanderbilt University Medical Center), Kathryn M. Edwards, Karen R. Broder, Theresa M. Dulski, Matthew E. Oster(Centers for Disease Control and Prevention), Colenda Arvelo Jefferson, Karen L. Shields(Centers for Disease Control and Prevention), Marcella Law, Kalah Kennebrew, Alejandra Ramirez‐Cardenas(Centers for Disease Control and Prevention), Nancy Kluisza, Brittney Romanson(Centers for Disease Control and Prevention), C. Buddy Creech(Vanderbilt University Medical Center), Michael J. Campbell(Duke University), Stephanie Gonsahn, Shannon Novosad(Centers for Disease Control and Prevention), David K. Shay(Centers for Disease Control and Prevention), Barbara Dyleski, Margaret M. Cortese(Centers for Disease Control and Prevention), Labretta Lanier Gholston, Bryan K. Kapella, Chidera Anugwom, Tchernavia Gregory, Sean M. Lang, Charlotte Kaboré, Melanie Feyereisen, Nastocia Bafford, Kara Jacobs Slifka, Mitesh Desai, Amy L. Valderrama(Centers for Disease Control and Prevention), Emmanuel B. Walter(Duke University), Paula Campbell(Duke University), Shelley S. Magill(Centers for Disease Control and Prevention)
Cited by 78
Related Papers
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017
|Infection Control and Hospital Epidemiology|2019|714
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
|JAMA|2022|670
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602